| Entry |
|
|---|
| Name |
Sodium nitroprusside (USP);
Sodium nitroprusside hydrate (JAN);
Nitropress (TN) |
|---|
| Product |
|
|---|
| Generic |
SODIUM NITROPRUSSIDE (Amneal Pharmaceuticals LLC), SODIUM NITROPRUSSIDE (Armas Pharmaceuticals), SODIUM NITROPRUSSIDE (Armas Pharmaceuticals), SODIUM NITROPRUSSIDE (AuroMedics Pharma LLC), SODIUM NITROPRUSSIDE (BE Pharmaceuticals), SODIUM NITROPRUSSIDE (Caplin Steriles Limited), SODIUM NITROPRUSSIDE (Cipla USA), SODIUM NITROPRUSSIDE (Dr.Reddy's Laboratories Inc.,), SODIUM NITROPRUSSIDE (Hainan Poly Pharm.), SODIUM NITROPRUSSIDE (Meitheal Pharmaceuticals), SODIUM NITROPRUSSIDE (Micro Labs Limited), SODIUM NITROPRUSSIDE (Mylan Institutional LLC), SODIUM NITROPRUSSIDE (Mylan Institutional LLC), SODIUM NITROPRUSSIDE (Nexus Pharmaceuticals), SODIUM NITROPRUSSIDE (Slate Run Pharmaceuticals), SODIUM NITROPRUSSIDE (Somerset Therapeutics), SODIUM NITROPRUSSIDE (Xiromed), SODIUM NITROPRUSSIDE IN 0.9% SODIUM CHLORIDE (Slate Run Pharmaceuticals) |
|---|
| Formula |
C5FeN6O. 2Na. 2H2O
|
|---|
| Exact mass |
297.949
|
|---|
| Mol weight |
297.9482
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG03231 Antihypertensive
|
|---|
| Remark |
| Therapeutic category: | 2149 |
| Product (DG00263): | D00614<JP/US> |
|
|---|
| Efficacy |
Antihypertensive, Vascular smooth muscle relaxant |
|---|
| Disease |
Acute heart failure [DS: H01631] |
|---|
| Comment |
Nitroferricyanide derivative
Nitric oxide donor
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DD Nitroferricyanide derivatives
C02DD01 Nitroprusside
D00614 Sodium nitroprusside (USP) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D00614 Sodium nitroprusside (USP); Sodium nitroprusside hydrate (JAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG03231 Antihypertensive
DG00263 Nitroprusside
D00614 Sodium nitroprusside
Drug classes [BR:br08332]
Cardiovascular agent
DG03231 Antihypertensive
D00614 Sodium nitroprusside
Drug groups [BR:br08330]
Cardiovascular agent
DG03231 Antihypertensive
DG00263 Nitroprusside
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 Z Fe -0.9310 0.0724 #2-
2 C3b C 0.0448 0.6690
3 C3b C -1.6310 0.5207
4 C3b C -0.2345 -0.3862
5 C3b C -0.9276 0.7621
6 C3b C -1.5931 -0.3517
7 N2b N -0.9310 -0.7345
8 N3a N 0.7069 1.0828
9 N3a N -2.3241 0.9759
10 N3a N 0.4621 -0.8379
11 N3a N -0.9241 1.4483
12 N3a N -2.2586 -0.7690
13 O3a O -0.9276 -1.6448
14 O0 O 3.7345 0.4793
15 O0 O 3.7345 -0.7828
16 Z Na 1.9966 0.3621 #+
17 Z Na 1.9966 -0.8655 #+
BOND 12
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 1 6 1
6 1 7 1
7 2 8 3
8 3 9 3
9 4 10 3
10 5 11 3
11 6 12 3
12 7 13 2
|
|---|
